Journal Information
Original Article
Full text access
Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin
Tuberculosis tras trasplante de pulmón. Experiencia multicéntrica de 27 años en España. Incidencia, presentación, prevención y uso de rifampicina en el tratamiento
Amparo Soléa,
, Mar Part-Lopezb, Berta Saezc, Rosalía Laportad, Gabriel Angueraa, Victor Mora Cuestae, Alicia De Pablof, Antonio J. Canyada-Martinezg, Amparo Pastora, Ana Gilh, José A. Camineroi, Carlos Bravoc
a Lung Transplant Unit, University and Politechnic Hospital La Fe, Valencia, Spain
b Medicine Department, University of Valencia, Valencia, Spain
c Pneumology Department and Lung Tranplant Unit, Universitary Hospital Vall d’Hebron, Barcelona, Spain
d Pneumology Department and Lung Trasplant Unit, Hospital Universitario Puerta de Hierro, Madrid, Spain
e Lung Transplant Unit, University Hospital Marqués de Valdecilla, IDIVAL, University of Cantabria, Santander, Spain
f Pneumology Department and Lung Tranplant Unit, University Hospital 12 de Octubre, Madrid, Spain
g Biostatistics Unit, Investigation Institute La Fe, Valencia, Spain
h Microbiology Department, University and Politechnic Hospital La Fe, Valencia, Spain
i Pneumology Department, General Hospital of Gran Canaria “Dr Negrin”, Las Palmas, Spain
Ver más

Article

This article is available in English

Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin

Amparo Solé, Mar Part-Lopez, Berta Saez, Rosalía Laporta, Gabriel Anguera, Victor Mora Cuesta, Alicia De Pablo, Antonio J. Canyada-Martinez, Amparo Pastor, Ana Gil, José A. Caminero, Carlos Bravo
10.1016/j.arbres.2019.10.013
Arch Bronconeumol. 2020;56:493-8
Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?